INADEQUATE RESPONSE TO INDUCTION CHEMOTHERAPY IN CHILDREN WITH HIGH-RISK NEUROBLASTOMA: AN INSTITUTIONAL

被引：0
|
作者：
Schrey, D. [1 ]
Vaidya, S. [1 ]
Levine, D. [1 ]
Moreno, L. [1 ]
Pearson, A. [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, London, England
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [41] High frequency of viridians group streptococci bacteremia in pediatric neuroblastoma high-risk patients during induction chemotherapy
    El Kebbi, Ola
    Prather, Cassandra S.
    Elmuti, Lena
    Khalifeh, Malak
    Alali, Muayad
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [42] High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma
    Yalcin, Bilgehan
    Kremer, Leontien C. M.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (10):
  • [43] High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma
    Yalcin, Bilgehan
    Kremer, Leontien C. M.
    Caron, Huib N.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [44] Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy
    Davidoff, AM
    Corey, BL
    Hoffer, FA
    Santana, VM
    Furman, WL
    Shochat, SJ
    PEDIATRIC BLOOD & CANCER, 2005, 44 (02) : 158 - 162
  • [45] A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma
    Furman, Wayne L.
    Federico, Sara M.
    McCarville, Mary Beth
    Shulkin, Barry L.
    Davidoff, Andrew M.
    Krasin, Matthew J.
    Sahr, Natasha
    Sykes, April
    Wu, Jianrong
    Brennan, Rachel C.
    Bishop, Michael William
    Helmig, Sara
    Stewart, Elizabeth
    Navid, Fariba
    Triplett, Brandon
    Santana, Victor M.
    Bahrami, Armita
    Anthony, Gwendolyn
    Yu, Alice L.
    Hank, Jacquelyn
    Gillies, Stephen D.
    Sondel, Paul M.
    Leung, Wing H.
    Pappo, Alberto S.
    CLINICAL CANCER RESEARCH, 2019, 25 (21) : 6320 - 6328
  • [46] P-Glycoprotein is a resistance mechanism for conventional induction chemotherapy but not ALK inhibitors in high-risk neuroblastoma
    Atkinson, Caroline
    Tactacan, Carole
    Kamili, Alvin
    Saletta, Federica
    Gana, Christine
    Eden, Georgina
    Mayoh, Chelsea
    Lock, Richard
    Norris, Murray
    Haber, Michelle
    Gifford, Andrew
    Trahair, Toby
    Fletcher, Jamie
    CANCER RESEARCH, 2020, 80 (14) : 61 - 61
  • [47] INCIDENCE OF ADRENAL INSUFFICIENCY IN CHILDREN WITH HIGH-RISK NEUROBLASTOMA
    Patterson, Kelli
    Horvath, Kyle
    Metzger, Gregory
    Bourgeois, Tran
    Stanek, Joseph
    Minneci, Peter
    Aldrink, Jennifer
    Streby, Keri
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S228 - S228
  • [48] Vitamin D Status in Children With High-risk Neuroblastoma
    Izurieta-Pacheco, Ana Carolina
    Sangros-Gimenez, Ana
    Martinez-Garcia, Esther
    Perez-Jaume, Sara
    Mora, Jaume
    Gorostegui-Obanos, Maite
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2023, 45 (08) : E953 - E958
  • [49] The efficacy of delayed surgery in children with high-risk neuroblastoma
    Ali, Varan
    Vural, Kesik
    Emin, Senocak Mehmet
    Gulsev, Kale
    Canan, Akyuz
    Munevver, Buyukpamukcu
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (02) : 268 - 271
  • [50] Evidence for the efficacy of immunotherapy in children with high-risk neuroblastoma
    Szychot, Elwira
    Peregud-Pogorzelski, Jaroslaw
    Wawrykow, Pawel
    Brodkiewicz, Andrzej
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 : 1001 - 1004
12345